A Multicentre Prospective Randomized Open-Label 12-Week Study With Blinded Evaluation Comparing the Efficacy and Safety of Irbesartan and Irbesartan-Hydrochlorothiazide Fixed Combination With Amlodipine and Amlodipine Plus Hydrochlorothiazide in Elderly Patients With Isolated Systolic Hypertension.
Phase of Trial: Phase IV
Latest Information Update: 07 Jul 2009
At a glance
- Drugs Irbesartan/hydrochlorothiazide (Primary) ; Amlodipine; Hydrochlorothiazide; Irbesartan
- Indications Isolated systolic hypertension
- Focus Therapeutic Use
- Acronyms AMISH
- Sponsors Sanofi
- 14 May 2008 Results have been presented at the 23rd Annual Scientific Meeting of the American Society of Hypertension.
- 13 Sep 2006 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History